Avexegen Therapeutics
San Diego
About Avexegen Therapeutics
Avexegen Therapeutics develops revolutionary therapies to promote gastro-intestinal health for patients with GI disorders. They offer an approach to directly heal damaged and inflamed gut tissue in patients with crohns disease and ulcerative colitis, as well as in premature infants with necrotizing enterocolitis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.2M
- Last round: Grant (Feb 2021)
- Website: avexegen.com
- Phone: (818) 288-6200
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/avexegen-therapeutics-51048 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.